357 related articles for article (PubMed ID: 12887186)
1. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
Han MG; Kim SJ
Avian Dis; 2003; 47(2):261-71. PubMed ID: 12887186
[TBL] [Abstract][Full Text] [Related]
2. Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
Thilakarathne DS; Coppo MJC; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Vaz PK; Devlin JM
PLoS One; 2019; 14(3):e0213866. PubMed ID: 30921344
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
[TBL] [Abstract][Full Text] [Related]
4. In ovo vaccination of commercial broilers with a glycoprotein J gene-deleted strain of infectious laryngotracheitis virus.
Mashchenko A; Riblet SM; Zavala G; García M
Avian Dis; 2013 Jun; 57(2 Suppl):523-31. PubMed ID: 23901771
[TBL] [Abstract][Full Text] [Related]
5. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Quinteros JA; Diaz-Méndez A; Thilakarathne D; Fakhri O; Vaz PK; Devlin JM
Vaccine; 2018 Sep; 36(38):5709-5716. PubMed ID: 30104116
[TBL] [Abstract][Full Text] [Related]
6. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
[TBL] [Abstract][Full Text] [Related]
7. Cross-protective immune responses between genotypically distinct lineages of infectious laryngotracheitis viruses.
Lee SW; Markham PF; Coppo MJ; Legione AR; Shil NK; Quinteros JA; Noormohammadi AH; Browning GF; Hartley CA; Devlin JM
Avian Dis; 2014 Mar; 58(1):147-52. PubMed ID: 24758128
[TBL] [Abstract][Full Text] [Related]
8. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
[TBL] [Abstract][Full Text] [Related]
9. Protection Induced in Broiler Chickens following Drinking-Water Delivery of Live Infectious Laryngotracheitis Vaccines against Subsequent Challenge with Recombinant Field Virus.
Korsa MG; Browning GF; Coppo MJ; Legione AR; Gilkerson JR; Noormohammadi AH; Vaz PK; Lee SW; Devlin JM; Hartley CA
PLoS One; 2015; 10(9):e0137719. PubMed ID: 26366738
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the transcriptional status of host cytokines and viral genes in the trachea of vaccinated and non-vaccinated chickens after challenge with the infectious laryngotracheitis virus.
Vagnozzi A; Riblet S; Zavala G; Ecco R; Afonso CL; García M
Avian Pathol; 2016; 45(1):106-13. PubMed ID: 26926298
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States.
Rodríguez-Avila A; Oldoni I; Riblet S; Garcia M
Avian Pathol; 2008 Jun; 37(3):287-92. PubMed ID: 18568655
[TBL] [Abstract][Full Text] [Related]
12. Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination.
Gimeno IM; Cortes AL; Guy JS; Turpin E; Williams C
Avian Pathol; 2011 Aug; 40(4):395-403. PubMed ID: 21812719
[TBL] [Abstract][Full Text] [Related]
13. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers.
Palomino-Tapia VA; Zavala G; Cheng S; García M
Avian Pathol; 2019 Jun; 48(3):209-220. PubMed ID: 30640536
[TBL] [Abstract][Full Text] [Related]
14. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
Legione AR; Coppo MJ; Lee SW; Noormohammadi AH; Hartley CA; Browning GF; Gilkerson JR; O'Rourke D; Devlin JM
Vaccine; 2012 Nov; 30(50):7193-8. PubMed ID: 23084851
[TBL] [Abstract][Full Text] [Related]
15. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
[TBL] [Abstract][Full Text] [Related]
16. Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines.
Vagnozzi A; García M; Riblet SM; Zavala G
Avian Dis; 2010 Dec; 54(4):1210-9. PubMed ID: 21313841
[TBL] [Abstract][Full Text] [Related]
17. Latency characteristics in specific pathogen-free chickens 21 and 35 days after intra-tracheal inoculation with vaccine or field strains of infectious laryngotracheitis virus.
Thilakarathne DS; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Coppo MJC; Devlin JM
Avian Pathol; 2020 Aug; 49(4):369-379. PubMed ID: 32352307
[TBL] [Abstract][Full Text] [Related]
18. Persistence and spreading of field and vaccine strains of infectious laryngotracheitis virus (ILTV) in vaccinated and unvaccinated geographic regions, in Brazil.
Chacón JL; Núñez LF; Vejarano MP; Parra SH; Astolfi-Ferreira CS; Ferreira AJ
Trop Anim Health Prod; 2015 Aug; 47(6):1101-8. PubMed ID: 25904510
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
Wei X; Shao Y; Han Z; Sun J; Liu S
Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
[TBL] [Abstract][Full Text] [Related]
20. Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.
Devlin JM; Hartley CA; Gilkerson JR; Coppo MJ; Vaz P; Noormohammadi AH; Wells B; Rubite A; Dhand NK; Browning GF
Vaccine; 2011 Aug; 29(34):5699-704. PubMed ID: 21689710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
